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Background: Bilateral chronic subdural hematoma (CSDH) is not uncommon, although information on
this condition is limited.
Aims: We aim to identify the differences in clinical characteristics between patients with bilateral or
unilateral CSDH.
Methods: Ninety-eight patients with CSDH were enrolled in the two-year retrospective study. We
investigated neurological outcome, morbidity, mortality, and recurrences after burr hole craniostomy for
CSDH.
Results: Bilateral convexity hematomas were identiﬁed in 25 of 98 CSDH (25.51%). The patients with
bilateral lesions had a lower incidence of hemiparesis than those having unilateral lesions (p ¼ 0.004).
Analysis of the neuro-images revealed signiﬁcant differences in the presence of a midline shift
(p ¼ 0.001) and thickness of the hematoma (p < 0.001). The mean Markwalder subdural hematoma
grade at admission was 1.89  0.66 and 1.64  0.49 in the unilateral and bilateral hematoma groups,
respectively (p ¼ 0.010). After a minimum follow-up period of 6 months, the mean Glasgow Outcome
Scale was not signiﬁcantly different (p ¼ 0.060). The recurrence rate of up to 28.00% observed for the
bilateral disease was found to be higher than 9.59% observed for the unilateral disease (p ¼ 0.042).
Conclusion: The frequency of focal neurological deﬁcits was found to be lesser in patients with bilateral
CSDH, and it may confound the diagnosis and delay treatment. To prevent neurological deterioration
resulting from the thicker hematomas, early surgical decompression for bilateral CSDH should be
implemented. Additionally, clinicians must be aware of the higher recurrent rate of bilateral CSDH after
burr hole craniostomy.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Chronic subdural hematoma (CSDH) is a well-known disease
that is often preceded by minor head trauma in which a bridging
vein tears, resulting in the collection of subdural blood. Although
unilateral convexity CSDH occurs in the majority of patients,
bilateral lesions are not uncommon in neurosurgical practices. The
overall incidence of bilateral CSDH has been reported to vary from
16% to 20%.1e3 Most clinicians consider bilateral CSDH equivalent to
unilateral CSDH as there is no difference in the presentations or
treatment strategies. However, rapid and progressive aggravation
of bilateral CSDH has been documented and the authorsery, Kaohsiung Chang Gung
rict, Kaohsiung City, Taiwan.
H. Huang).
ciates Ltd. Published by Elsevier Ltrecommend operation as early as possible with simultaneous
decompression of bilateral hematoma pressure.4 Furthermore
bilateral sites of CSDH are identiﬁed as a risk factor for recurrence
by some researchers.3,5 All these reports suggest that bilateral
CSDH has a different clinical signiﬁcance, and hence, should be
distinguished from unilateral cases in order to establish an appro-
priate management.
We retrospectively collected data and analyzed clinical mani-
festations and neuro-imaging ﬁndings or measurements in patients
with CSDH. We investigated prognosis following the surgical
intervention, including neurological outcomes, morbidity, mortal-
ity, and recurrence.
2. Materials and methods
From January of 2005 to December of 2006, 151 patients diagnosed as CSDH
were admitted to Kaohsiung Chang Gung Memorial Hospital, the medical center in
southern Taiwan. Criteria of CSDH for inclusion were: 1) when the hematoma wasd. All rights reserved.
Table 1
Incidence of clinical presentations in patients with unilateral and bilateral CSDH.
Unilateral CSDH Bilateral CSDH
N ¼ 73 N ¼ 25
Symptoms and signs N/(%) N/(%)
Headache 29 (39.73) 12 (48.00)
Nausea or vomiting 19 (26.03) 5 (20.00)
Hemiparesis 45 (61.64) 7 (28.00)
Mental change 35 (47.95) 12 (48.00)
Seizure 3 (4.11) 1 (4.00)
N: number of patients.
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ORIGINAL RESEARCHﬂuid (usually >21 days after injury) identiﬁed at the time of surgery; and 2)
Computerized tomography (CT) scan showed isodense to hypodense hematomas
with respect to the adjacent brain.6 Patients were excluded if: 1) they had
concomitant occurrences of other types of traumatic brain injury; 2) CSDH had
resulted from complications of prior neurosurgical procedures, such as craniotomy
or cerebrospinal ﬂuid shunting; 3) they were receiving conservative treatment
without surgery; 4) the images of the brain could not be assessed because of missing
data or poor quality. Thus, only of the 98 patients were enrolled for analysis. The
study protocol was approved by the Institutional Review Committee on Human
Research at the Chang Gung Memorial Hospital.
All of the patients received brain CT scans soon after arrival at the emergency
room. Follow-up CT scans were obtained in the case of acute onset of focal neuro-
logical deﬁcits, progressively disturbed consciousness, as well as post-neurosurgical
procedures. Brain CT scans were interpreted by the ﬁndings: (1) the site of the he-
matoma (unilateral or bilateral cerebral convexity); (2) the thickness of the hema-
toma measured at the maximal diameter of the unilateral hematoma or the sum of
both the maximal diameters of the bilateral hematoma; (3) midline shift identiﬁed
as deviation of the septum pellucidum by more than 1 cm from the central position;
(4) mass effect determined by effacement of the sulci, sylvian ﬁssure obscuration, or
compression of lateral ventricles; (5) layering of the hematoma, deﬁned as con-
taining 2 components of different densities with a clear boundary between them;
and (6) multiplicity of hematoma cavities, deﬁned as a hematoma with inhomo-
geneous content and a high-density septum running between the inner and outer
membranes.7 We also measured the Hounsﬁeld units (HU) of the hematomas at the
sites of highest density.
Surgery was indicated when the clinical presentations were compatible with
the CT abnormalities, including the presence of a mass effect or midline shift. The
initial surgical procedure was performed using 1 or 2 burr holes at each affected
side of the CSDH for irrigation of the hematoma. All the patients underwent
closed-system drainage, performed with the aid of a silicone tube indwelled in
the subdural space and tunneled under the scalp to the exit point of the incision
line. The drains were removed once drainage had stopped or decreased, and the
patients showed an improvement in initial symptoms. Craniotomy was reserved
for patients in whom the subdural hematoma was recurrent and the underlying
membranes prevented adequate re-expansion of the brain. The clinical and
radiological criteria were integrated to evaluate CSDH recurrence. Reappearance
of symptoms such as hemiparesis, headache, or change in consciousness indi-
cated the accumulation of subdural hematoma. The radiological criteria consisted
of an increase in the thickness of hematoma and a change in the density of he-
matoma on the treated side, in follow-up CT scans within 3 months post-
operatively.8
Clinical characteristics of the 98 patients were documented. The presenting
symptoms comprised headache, nausea or vomiting, hemiparesis, mental change,
or seizure that occurred in close temporal relationship with CSDH presuming the
etiology. The Glasgow Coma Scale (GCS) and Markwalder Subdural Hematoma
Grade9 were determined by the neurosurgeons when the patient arrived at the
emergency room. Post-operative morbidity consisting of acute subdural hemor-
rhage, infection of the central nervous system, new-onset seizure, pneumonia,
urinary tract infection was identiﬁed, and the length of hospital stay was recorded.
Neurological outcome was assessed at the end of the follow-up period using the
Glasgow Outcome Scale (GOS). The patients were followed-up at the out-patient
department after discharge.
All statistical analyses were conducted using SPSS version 12.0 (SPSS Inc., Chi-
cago, IL). The quality of the means for continuous variables was assessed using
Student’s t-test or ManneWhitney U-test. Categorical variables were analyzed using
chi-square test or Fisher’s exact test. A P-value of 0.05 or less was considered sta-
tistically signiﬁcant.
3. Results
The 98 patients (81 males and 17 females) diagnosed with CSDH
had a mean age of 69.30  12.76 years. The mean duration of
follow-up was 10.66  10.14 months. Seventy-three patients had a
deﬁnite history of head injury. The mechanisms of head injury
comprised 28 cases of trafﬁc accidents, 34 cases of falls, and 11
cases of collision with heavy objects. The incidence of bilateral le-
sions was 25.51% (25/98) among all the CSDH. The clinical charac-
teristics of the unilateral and bilateral CSDH groups are compared
below.
Differences in the gender (p ¼ 0.761) and mean age (p ¼ 0.480)
were not statistically signiﬁcant. There were no differences in the
presentation of head injury history (p ¼ 0.741) (Table 2). The
prevalence of underlying diseases including hypertension, diabetes
mellitus, stroke or others was similar between the unilateral and
bilateral CSDH subjects.The incidence of the presenting symptoms in the 2 groups is
listed in Table 1. Statistical analyses revealed a signiﬁcant inter-
group difference only in the occurrence of hemiparesis (p ¼ 0.004),
but no differences were found in the case of headache (p ¼ 0.469),
seizure (p ¼ 1.000), nausea or vomiting (p ¼ 0.545), or mental
change (p ¼ 0.996). The mean GCS at admission was 13.82  2.32
and 14.36  0.99 in the unilateral and bilateral CSDH patients,
respectively (p ¼ 0.756). The mean Markwalder subdural hema-
toma grade was 1.89  0.66 and 1.64  0.49 in the unilateral and
bilateral hematoma groups, respectively, and there was statistically
signiﬁcant (p ¼ 0.010).
Brain CT scans at admission revealed the presence of a midline
shift in 36 of the 73 unilateral CSDH and 3 of the 25 bilateral CSDH
(p ¼ 0.001). The difference in thickness of the hematomas was
19.88  8.63 mm and 32.16  10.81 mm in the unilateral and
bilateral hematoma patients, respectively (p < 0.001). Examples of
CT scans are illustrated in Fig. 1. The mean HU of the hematomawas
35.03  11.13 in the unilateral CSDH subjects and 35.80  11.30 in
the bilateral CSDH subjects (p¼ 0.766). The other features of the CT
scans showed no signiﬁcant differences for the presence of a mass
effect (p ¼ 1.000), layering of the hematoma (p ¼ 0.953), and
multiplicity of hematoma cavities (p ¼ 0.057). The baseline clinical
features and neuro-imaging ﬁndings of the 2 groups are compared
in Table 2.
All the patients initially underwent burr hole craniostomy.
Within 3 months after the operation, recurrence of CSDH was
found in 7 of the 73 unilateral CSDH patients and 7 of the 25
bilateral CSDH patients. The incidence of recurrence was 9.59%
and 28.00%, respectively (p ¼ 0.042). Morbidity after the man-
agement of CSDH included 1 acute subdural hemorrhage, 7 new-
onset seizures, 4 cases of pneumonia, and 4 cases of urinary tract
infection. No infection of the central nervous system was
observed. Overall post-operative morbidity occurred in 9 of the 73
unilateral CSDH patients and 4 of the 25 bilateral CSDH patients
(p ¼ 0.734). Of the 73 patients with unilateral CSDH, 1 died from
respiratory failure due to severe pneumonia and 1 died due to
non-Hodgkin lymphoma during the follow-up period. One of the
25 patients with bilateral CSDH died from pneumonia compli-
cated with respiratory failure. There was no statistically signiﬁ-
cant intergroup difference in mortality after the treatment of
CSDH (p ¼ 1.000). Neurological outcomes after a minimum
follow-up period of 6 months were determined by GOS and as
follows: 74 patients were leading a normal life, 18 had moderate
disabilities, 1 had severe disabilities, 2 were in a persistent
vegetative state, and 3 had died. The mean GOS score at the end of
the follow-up was 4.66  0.87 and 4.48  0.87 for patients in the
unilateral and bilateral CSDH groups, respectively (p ¼ 0.060). The
mean hospital stay was 12.81  12.79 and 14.24  13.36 days for
the patients in the unilateral and the bilateral hematoma groups,
respectively (p ¼ 0.634). Comparison of therapeutic outcomes and
recurrence between patients with unilateral and bilateral CSDH is
given in Table 3.
Table 2
Comparisons of clinical features and neuro-imaging ﬁndings between unilateral and bilateral CSDH patients.
Unilateral CSDH
N ¼ 73
Bilateral CSDHs
N ¼ 25
P-value OR 95% CI
Mean age at onset (year) 69.93  11.46 67.44  16.09 0.480
Gender (male/female) 61/12 20/5 0.761 0.787 0.247e2.508
Head injury history 55 18 0.741 0.842 0.303e2.340
Underlying medical condition
Diabetes mellitus 22 7 0.840 0.902 0.330e2.465
End stage renal disease with hemodialysis 1 1 0.447 3.000 0.181e49.832
Hypertension 37 14 0.646 1.238 0.497e3.087
Stroke 12 5 0.761 1.271 0.399e4.050
Dementia 5 2 1.000 1.183 0.215e6.516
Alcoholism 11 3 1.000 0.769 0.196e3.013
Antiplatelet therapy 8 5 0.307 2.031 0.597e6.912
Anticoagulant therapy 2 0 1.000
Symptom/sign
Headache 29 12 0.469 1.401 0.561e3.493
Nausea or vomiting 19 5 0.545 0.711 0.234e2.158
Hemiparesis 45 7 0.004* 0.242 0.090e0.653
Mental change 35 12 0.996 1.002 0.404e2.488
Seizure 3 1 1.000 0.972 0.096e9.796
Mean GCS at admission 13.82  2.32 14.36  0.99 0.756
Mean Markwalder SDH Grade at admission 1.89  0.66 1.64  0.49 0.010*
Neuro-image ﬁndings
Midline shift 36 3 0.001* 0.140 0.039e0.509
Mass effect 70 24 1.000 1.029 0.102e10.364
Presence of layering 15 5 0.953 0.967 0.311e3.000
Multiplicity of hematoma cavities 30 5 0.057 0.358 0.121e1.061
Thickness of hematoma (mm) 19.88  8.63 32.16  10.81 <0.001*
Density of hematoma (HU) 35.03  11.13 35.80  11.30 0.766
N¼ number of cases; OR: odds ratio, CI: conﬁdence interval; HU¼ Hounsﬁeld unit; SDH¼ subdural hemorrhage; GCS ¼ Glasgow Coma Scale; GOS¼ Glasgow Outcome Scale.
The signiﬁcance of bold is P < 0.05.
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The incidence of bilateral CSDH in this series is 25.51%, which is
close to the percentage reported in previous studies.1e3 Although
the pathophysiology of bilateral CSDH is not well understood, like
that of unilateral CSDH, it is postulated that traumatic injury to the
bridging veins leads to subdural hemorrhage. Several risk factors
for bilateral CSDH have been identiﬁed, and they include age (more
than 75 years), coagulopathy, use of antiplatelet or anticoagulation
medications, and hemodialysis.10,11 However, our analysis does notFig. 1. Brain CT scans at admission. (A) A 75-year-old male patient presented with right hem
deep cerebral structures shifted to right side more than 1 cm (B) A 78-year-old male patient
both the maximal diameters of the subdural hematoma was 43.75 mm but the midline ofidentify the above mentioned risk factors that predispose the
development of bilateral CSDH.
The clinical presentations of bilateral CSDH are usually variable,
and several authors have reported uncommon symptoms. Okudera
et al. described a case of divergence gaze palsy associated with
bilateral CSDH.12 Schaller et al. documented intermittent para-
paresis as a clinical feature of the disorder.13 There are other cases
of bilateral CSDH that have been presented with depression or
sudden explosive headache mimicking subarachnoid hemor-
rhage.14,15 In our study, it is an interesting ﬁnding that theiparesis for a few days. The thickness of left convexity hematomawas 30.74 mm and the
complained of impaired memory, without hemiparesis, since 2 months ago. The sum of
the brain still maintained in the central position.
Table 3
Comparison of the prognosis of patients with unilateral and bilateral CSDH after surgical decompression.
Unilateral CSDH
N ¼ 73
Bilateral CSDHs
N ¼ 25
P-value OR 95% CI
Mean hospital stay (day) 12.81  12.79 14.24  13.36 0.634
Post-operative morbidity 9 4 0.734 1.354 0.378e4.856
Post-operative mortality 2 1 1.000 1.479 0.128e17.050
Mean GOS at the end of follow-up 4.66  0.87 4.48  0.87 0.060
Recurrence of CSDH 7 7 0.042* 3.667 1.138e11.815
N: number of patients, OR: odds ratio, CI: conﬁdence interval, GOS: Glasgow Outcome Scale.
The signiﬁcance of bold is P < 0.05.
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bilateral CSDH. Tanaka et al. suggest that CSDH may induce
neurological dysfunction primarily through mechanical distortion
of the central brain regions, with an inﬂuence on the remote re-
gions owing to transneural depression.16 Okuyama et al. measure
cerebral blood ﬂow (CBF) in 34 patients with bilateral CSDH. In the
brain shifted group, the CBF reductions are noted in the frontal,
parietal and occipital cortices in the thin hematoma side, and in the
putamen in the thick hematoma side.17 These results suggest that
the shifted force of the CSDH is accompanied by a secondary CBF
reduction in the deep cerebral regions and it is a major cause of
neurological dysfunction. We discovered that the presence of a
midline shift occurred less often in the bilateral CSDH group.
Although the average thickness of the bilateral hematoma was
greater than that of the unilateral hematoma, patients with a
bilateral CSDH have less opportunity for central brain structures to
deviate owing to counterbalance of the mass effect on both sides.
This is why patients with bilateral CSDH had a lower incidence of
hemiparesis in our analysis. As a result, patients with bilateral
CSDH may present with vague symptoms instead of focal neuro-
logical deﬁcits or these patients may be identiﬁed incidentally
during an unrelated workup. In a study of 236 cases, Penchet et al.
noticed a difference in the duration of the pre-diagnostic period
between the unilateral and bilateral CSDH.2 We consider that the
pre-diagnostic period is inﬂuenced by the different incidence of
neurological manifestations. The clinical signiﬁcance of these
neurological features should not be overlooked as delayed or
missed diagnosis is more likely in patients with bilateral CSDH.
There are a few literatures that discuss the clinical course of
bilateral CSDH. Kurokawa et al. analyzed 98 patientswith CSDH, and
14 patients were shown to have a bilateral CSDH with a minimum
degree or lacking any neurological deﬁcits at the time of diagnosis.
Of these 14 cases, 6 had aggravation of their symptoms with
neurological deterioration occurring rapidly within 19e54 h.4
Although our data show that bilateral CSDH patients have better
Markwalder subdural hematoma grade at the time of diagnosis, this
may progress within a short period of time. Theoretically, a
considerable amount of the hematoma occupies more intracranial
volume in bilateral CSDHpatients. The patients aremore susceptible
and unable to buffer the raised intracranial pressure. They cannot
endure the expansion of the subdural hematoma, even at a slow rate
or with small increase in volume. Ultimately, circulatory compro-
mise results in rapid depression of neural activity with extensive
involvement of the bilateral cerebral hemispheres. Therefore,
despite amore favorable initial neurological condition, early surgical
decompression for bilateral CSDH should be implemented.
Improvement in the prognosis of CSDH has been achieved after
the introduction of modern imaging methods and operative tech-
niques.18 The disease is often considered to be a benign entity at
present, and the satisfactory results can also be applied to the sub-
group of bilateral CSDH according to our analysis. Even though the
thickness or volumeof thebilateral hematomaexceeded those of the
unilateral form, neurological outcome after surgery was similar inthe 2 groups. This ﬁnding implies that early and rapid surgical
drainage of bilateral hematomas is feasible and may improve
neurological recovery as effectively as for unilateral hematoma.
Torihashi et al. reviewed 343 cases of CSDH, including 61 patients
who had a recurrence. Univariate and multivariate analyses show
that a bilateral CSDH was an independent predictor for the recur-
rence of CSDH.19 Earlier studies also concluded that bilateral CSDH
was a risk factor for recurrence.3,5 We obtained the same result, a
higher recurrent rate of bilateral CSDH. Poor brain re-expansion has
been shown to be correlated with the recurrence of CSDH, and it is
thought that this abnormality creates the potential for recurrence of
the hematoma.3,20 In addition, Omaya also reported that bilateral
CSDH occurred more frequently in patients with prolonged coagu-
lation time.11 Whether coagulopathy or other types of bleeding
tendency predisposes to the higher recurrent rate found in the pa-
tientswith a bilateral CSDH is unknown. Further studies are required
to evaluate the association between recurrence and bilateral CSDH.
The disadvantage of our investigation was its retrospective
design. Data collection through chart and imaging reviews is less
complete and accurate than is planned research. Variations in the
assessment of neurological status account for the observed differ-
ences in results. The period of evaluation of neurological outcomes
varies and follow up information is difﬁcult to obtain without
scheduled returns to the clinic. Despite these miscellaneous limi-
tations, this study provides useful preliminary information to
identify the differences in clinical features between unilateral and
bilateral CSDH patients, which can optimize the timing of diagnosis
and establish therapeutic strategies.
5. Conclusion
The frequency of focal neurological deﬁcits was found to be
lesser in patients with bilateral CSDH, and this may confound the
diagnosis and delay the treatment. Moreover, bilateral CSDH is
thicker than unilateral hematoma, and it reduces the autonomic
capacity for buffering of the increased intracranial pressure.
Therefore, early surgical decompression of bilateral mass lesions
should be implemented to prevent rapid neurological deteriora-
tion. Although there is no difference in the eventual neurological
outcomes, it is important for clinicians to be aware of the higher
incidence of recurrence in patients with bilateral CSDH.
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